Phototherpy Versus Tapwater Iontophoresis for Management of Atopic Dermatitis in Children.
Atopic Dermatitis
About this trial
This is an interventional treatment trial for Atopic Dermatitis focused on measuring Atopic dermatitis, Phototherapy, iontophoresis
Eligibility Criteria
Inclusion Criteria:
- Age between 9 to 16 years.
- Suffering from AD of dyshidrotic as well as dry types of more than 6-months duration
- Traditional types of treatment options, including oral or topical corticosteroids, proved ineffective.
Exclusion Criteria:
- Intolerance history to UV radiation.
- Skin malignancy at the area to be treated.
- Acute infection at the treated area.
- Children received radiotherapy in the area to be treated during the last 6 months.
- Children received corticosteroid therapy topically within 14 days before treatment, or systemic corticosteroids or any immunosuppressive drugs within the last 4 weeks.
- Circulatory and sensory disorders and children with diabetes mellitus.
Sites / Locations
- Banha University
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Active Comparator
Phototherapy "PUVA" +traditional medical treatmentn
Tap Water Iontophoresis + Traditional medical treatment
traditional medical treatment
patient sock his hands in a bath containing water with the constitution of psoralen "meladinine " capsule for 20 minutes then irradiated at the UVA device for 3 sessions per week for 8 weeks Plus the traditional medical treatment. which is the betamethasone dipropionate 0.05% " diprolene for 2 times a day for 8 weeks.
Tap-water iontophoresis was given 3 times weekly for 10 min The direct current level was slowly increased, guided by the occurrence of tingling sensations. The maximum level was 30mA. Plus the traditional medical treatment. which is the betamethasone dipropionate 0.05% " diprolene for 2 times a day for 8 weeks.
Traditional medical treatment. which is the betamethasone dipropionate 0.05% " diprolene for 2 times a day for 8 weeks.